» Articles » PMID: 29451543

Sex and Gender Equity in Research: Rationale for the SAGER Guidelines and Recommended Use

Overview
Publisher Biomed Central
Date 2018 Feb 17
PMID 29451543
Citations 563
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Sex and gender differences are often overlooked in research design, study implementation and scientific reporting, as well as in general science communication. This oversight limits the generalizability of research findings and their applicability to clinical practice, in particular for women but also for men. This article describes the rationale for an international set of guidelines to encourage a more systematic approach to the reporting of sex and gender in research across disciplines.

Methods: A panel of 13 experts representing nine countries developed the guidelines through a series of teleconferences, conference presentations and a 2-day workshop. An internet survey of 716 journal editors, scientists and other members of the international publishing community was conducted as well as a literature search on sex and gender policies in scientific publishing.

Results: The Sex and Gender Equity in Research (SAGER) guidelines are a comprehensive procedure for reporting of sex and gender information in study design, data analyses, results and interpretation of findings.

Conclusions: The SAGER guidelines are designed primarily to guide authors in preparing their manuscripts, but they are also useful for editors, as gatekeepers of science, to integrate assessment of sex and gender into all manuscripts as an integral part of the editorial process.

Citing Articles

Personalization of Cancer Treatment: Exploring the Role of Chronotherapy in Immune Checkpoint Inhibitor Efficacy.

Fey R, Billo A, Clister T, Doan K, Berry E, Tibbitts D Cancers (Basel). 2025; 17(5).

PMID: 40075580 PMC: 11899640. DOI: 10.3390/cancers17050732.


Exploring the impact of gender-related variables on health measures and perceived stress.

Pico-Perez M, Coelho M, Vieira R, Machado-Sousa M, Morgado P Front Psychol. 2025; 16:1500674.

PMID: 40070898 PMC: 11893839. DOI: 10.3389/fpsyg.2025.1500674.


Excess mortality and years of life lost from 2020 to 2023 in France: a cohort study of the overall impact of the COVID-19 pandemic on mortality.

Moulaire P, Hejblum G, Lapidus N BMJ Public Health. 2025; 3(1):e001836.

PMID: 40051536 PMC: 11883889. DOI: 10.1136/bmjph-2024-001836.


Effect of living in well-insulated warm houses on hypertension and cardiovascular diseases based on a nationwide epidemiological survey in Japan: a modelling and cost-effectiveness analysis.

Umishio W, Ikaga T, Kario K, Fujino Y, Kagi N, Suzuki M BMJ Public Health. 2025; 2(2):e001143.

PMID: 40018632 PMC: 11816841. DOI: 10.1136/bmjph-2024-001143.


Prevalence of unplanned first pregnancy and socioeconomic factors in Benin: a cross-sectional and analytical study.

Mintogbe M, Adje E, Dougnon V, Ahoussinou C, Sanni M BMJ Public Health. 2025; 2(2):e000878.

PMID: 40018532 PMC: 11816289. DOI: 10.1136/bmjph-2023-000878.


References
1.
. Taking sex into account in medicine. Lancet. 2011; 378(9806):1826. DOI: 10.1016/S0140-6736(11)61795-9. View

2.
Doull M, Runnels V, Tudiver S, Boscoe M . Appraising the evidence: applying sex- and gender-based analysis (SGBA) to Cochrane systematic reviews on cardiovascular diseases. J Womens Health (Larchmt). 2010; 19(5):997-1003. DOI: 10.1089/jwh.2009.1626. View

3.
Zhou Q . [Recommendations for the conduct, reporting, editing and publication of scholarly work in medical journals]. Zhonghua Gan Zang Bing Za Zhi. 2015; 22(10):781-91. View

4.
Zarin D, Tse T, Ide N . Trial Registration at ClinicalTrials.gov between May and October 2005. N Engl J Med. 2005; 353(26):2779-87. PMC: 1568386. DOI: 10.1056/NEJMsa053234. View

5.
Leopold S, Beadling L, Dobbs M, Gebhardt M, Lotke P, Manner P . Fairness to all: gender and sex in scientific reporting. Clin Orthop Relat Res. 2013; 472(2):391-2. PMC: 3890179. DOI: 10.1007/s11999-013-3397-5. View